2-1943142-A-G

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1

The NM_001303052.2(MYT1L):​c.345T>C​(p.Asp115Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.375 in 1,531,704 control chromosomes in the GnomAD database, including 112,928 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.45 ( 16289 hom., cov: 27)
Exomes 𝑓: 0.37 ( 96639 hom. )

Consequence

MYT1L
NM_001303052.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:3

Conservation

PhyloP100: -1.59

Publications

16 publications found
Variant links:
Genes affected
MYT1L (HGNC:7623): (myelin transcription factor 1 like) This gene encodes a member of the zinc finger superfamily of transcription factors whose expression, thus far, has been found only in neuronal tissues. The encoded protein belongs to a novel class of cystein-cystein-histidine-cystein zinc finger proteins that function in the developing mammalian central nervous system. Forced expression of this gene in combination with the basic helix-loop-helix transcription factor NeuroD1 and the transcription factors POU class 3 homeobox 2 and achaete-scute family basic helix-loop-helix transcription factor 1 can convert fetal and postnatal human fibroblasts into induced neuronal cells, which are able to generate action potentials. Mutations in this gene have been associated with an autosomal dominant form of cognitive disability and with autism spectrum disorder. Alternative splicing results in multiple variants. [provided by RefSeq, Jul 2017]
MYT1L Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal dominant 39
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 2-1943142-A-G is Benign according to our data. Variant chr2-1943142-A-G is described in ClinVar as Benign. ClinVar VariationId is 1174838.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-1.59 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.644 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYT1LNM_001303052.2 linkc.345T>C p.Asp115Asp synonymous_variant Exon 9 of 25 ENST00000647738.2 NP_001289981.1 Q9UL68-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYT1LENST00000647738.2 linkc.345T>C p.Asp115Asp synonymous_variant Exon 9 of 25 NM_001303052.2 ENSP00000497479.2 Q9UL68-1

Frequencies

GnomAD3 genomes
AF:
0.447
AC:
66766
AN:
149422
Hom.:
16250
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.650
Gnomad AMI
AF:
0.292
Gnomad AMR
AF:
0.337
Gnomad ASJ
AF:
0.370
Gnomad EAS
AF:
0.632
Gnomad SAS
AF:
0.370
Gnomad FIN
AF:
0.392
Gnomad MID
AF:
0.367
Gnomad NFE
AF:
0.356
Gnomad OTH
AF:
0.417
GnomAD2 exomes
AF:
0.390
AC:
60127
AN:
154224
AF XY:
0.385
show subpopulations
Gnomad AFR exome
AF:
0.652
Gnomad AMR exome
AF:
0.335
Gnomad ASJ exome
AF:
0.368
Gnomad EAS exome
AF:
0.637
Gnomad FIN exome
AF:
0.379
Gnomad NFE exome
AF:
0.352
Gnomad OTH exome
AF:
0.369
GnomAD4 exome
AF:
0.367
AC:
507688
AN:
1382168
Hom.:
96639
Cov.:
28
AF XY:
0.366
AC XY:
249711
AN XY:
682880
show subpopulations
African (AFR)
AF:
0.657
AC:
20491
AN:
31192
American (AMR)
AF:
0.336
AC:
11979
AN:
35688
Ashkenazi Jewish (ASJ)
AF:
0.366
AC:
9164
AN:
25060
East Asian (EAS)
AF:
0.622
AC:
22188
AN:
35664
South Asian (SAS)
AF:
0.358
AC:
28246
AN:
78858
European-Finnish (FIN)
AF:
0.383
AC:
18960
AN:
49454
Middle Eastern (MID)
AF:
0.354
AC:
2005
AN:
5664
European-Non Finnish (NFE)
AF:
0.350
AC:
372233
AN:
1063026
Other (OTH)
AF:
0.390
AC:
22422
AN:
57562
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
16895
33791
50686
67582
84477
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12130
24260
36390
48520
60650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.447
AC:
66845
AN:
149536
Hom.:
16289
Cov.:
27
AF XY:
0.447
AC XY:
32505
AN XY:
72790
show subpopulations
African (AFR)
AF:
0.650
AC:
26452
AN:
40672
American (AMR)
AF:
0.337
AC:
5038
AN:
14948
Ashkenazi Jewish (ASJ)
AF:
0.370
AC:
1278
AN:
3452
East Asian (EAS)
AF:
0.631
AC:
3173
AN:
5028
South Asian (SAS)
AF:
0.369
AC:
1715
AN:
4648
European-Finnish (FIN)
AF:
0.392
AC:
3932
AN:
10040
Middle Eastern (MID)
AF:
0.356
AC:
104
AN:
292
European-Non Finnish (NFE)
AF:
0.356
AC:
24034
AN:
67484
Other (OTH)
AF:
0.413
AC:
854
AN:
2066
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1659
3319
4978
6638
8297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
608
1216
1824
2432
3040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.374
Hom.:
17313
Bravo
AF:
0.453
Asia WGS
AF:
0.494
AC:
1714
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.066
DANN
Benign
0.21
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3748988; hg19: chr2-1946914; COSMIC: COSV67734138; API